Summary
UnitedHealth Group Inc. (UNH) announced a significant leadership change via an 8-K filing on November 13, 2019, detailing the appointment of Sir Andrew Witty as the company's new President, effective November 7, 2019. Sir Andrew Witty will continue in his role as CEO of Optum while taking on this expanded responsibility. This appointment is accompanied by an equity award designed to incentivize performance and align leadership with shareholder value. The award includes stock options, restricted stock units, and performance shares, with specific vesting schedules over four and three years, respectively. Investors should note that while this appointment represents a key executive transition, the core aspects of Sir Andrew Witty's compensation remain unchanged. The filing also incorporates by reference his extensive background from the company's 2018 10-K, assuring stakeholders of his qualifications. The inclusion of a press release as an exhibit further provides context and elaboration on this strategic leadership move. This development signals a continued focus on strengthening the executive team to drive future growth and operational excellence.
Key Highlights
- 1Sir Andrew Witty appointed President of UnitedHealth Group, in addition to his role as CEO of Optum.
- 2Appointment is effective November 7, 2019.
- 3Witty awarded 17,845 stock options, 2,994 restricted stock units, and 5,988 performance shares.
- 4Stock options and RSUs vest ratably over a four-year period.
- 5Performance shares have a three-year cliff vesting schedule with performance criteria.
- 6Other aspects of Witty's compensation remain unaffected.
- 7Filing includes a press release dated November 11, 2019, as Exhibit 99.1.